REPL
Replimune Group, Inc.
Healthcare · Biotechnology · NMS
$4.88
Close 2026-05-22
✗ ETHICAL FAIL
HIGH
Data Confidence: 100%
Full financial profile available
Market Cap
$403.4M
Trailing P/E
—
Forward P/E
-2.35
Rev Growth
—
Profit Margin
0.0%
ROE
-90.9%
Analyst Target
$3.50
Recommendation
NONE
Ethical Screen
| Business Activity | PASS |
| Debt Ratio (0.19%) | PASS |
| Cash Ratio (0.67%) | FAIL |
| Receivables Ratio (0.00%) | PASS |
| Revenue Ratio (0.00%) | PASS |
| Overall | FAIL |
Score Valuation: 33.0
Score Quality: 20.0
Score Combined: 33.8
Opportunity Scores
Valuation50.0
Quality6.2
Cash Flow50.0
Moat50.0
Balance Sheet92.9
Debt Purity42.6
Liquid Purity0.0
Rev Purity100.0
Compliance47.0
Tier: BRONZE · Score: 47.4 · Rank: #2530
Earnings History (Last 8 Quarters)
| Date | EPS Est. | Reported EPS | Surprise % |
|---|---|---|---|
| 2026-05-26 | -0.73 | Pending | -- |
| 2026-02-03 | -0.82 | -0.77 | +6.5% |
| 2025-11-06 | -0.79 | -0.90 | -13.5% |
| 2025-08-07 | -0.80 | -0.95 | -19.2% |
| 2025-05-22 | -0.69 | -0.82 | -18.8% |
| 2025-02-12 | -0.72 | -0.79 | -9.6% |
| 2024-11-12 | -0.74 | -0.68 | +7.7% |
| 2024-08-08 | -0.83 | -0.78 | +6.6% |
Quarterly Financials
| Period | Revenue | Net Income | EBITDA | Gross Profit | Op. Income | EPS |
|---|---|---|---|---|---|---|
| 2025-12-31 | — | -$70.9M | -$68.4M | — | -$71.5M | -0.77 |
| 2025-09-30 | — | -$83.1M | -$80.3M | — | -$83.9M | -0.90 |
| 2025-06-30 | — | -$86.7M | -$83.8M | — | -$90.0M | -0.95 |
| 2025-03-31 | — | -$74.1M | -$71.4M | — | -$78.8M | — |
| 2024-12-31 | — | -$66.3M | -$62.8M | — | -$65.6M | -0.79 |
| 2024-09-30 | — | — | — | — | — | -0.68 |
Insider Transactions
| Date | Name | Role | Shares | Value |
|---|---|---|---|---|
| 2026-05-18 | SARCHI CHRISTOPHER | Officer | 8,626 | $43.8K |
| 2026-05-18 | ASTLEY-SPARKE PHILIP | Director | 17,657 | $89.7K |
| 2026-05-18 | HILL EMILY LUISA | Chief Financial Officer | 7,812 | $39.7K |
| 2026-05-18 | PATEL SUSHIL | Chief Executive Officer | 37,324 | $189.6K |
| 2026-05-18 | XYNOS KONSTANTINOS | Officer | 14,023 | $71.2K |
| 2026-05-18 | SCHWENDENMAN ANDREW | Officer | 7,894 | $40.1K |
| 2026-04-02 | SARCHI CHRISTOPHER | Officer | 6,500 | $52.1K |
| 2026-04-01 | ASTLEY-SPARKE PHILIP | Director | 50,000 | -- |
| 2026-04-01 | HILL EMILY LUISA | Chief Financial Officer | 50,000 | -- |
| 2026-04-01 | PATEL SUSHIL | Chief Executive Officer | 251,240 | -- |
Top Institutional Holders
| Holder | Shares | Value | % Held |
|---|---|---|---|
| Baker Bros. Advisors, LP | 11.0M | $54.2M | 0.1% |
| Price (T.Rowe) Associates Inc | 8.1M | $39.9M | 0.1% |
| RTW Investments LP | 7.4M | $36.1M | 0.1% |
| Blackrock Inc. | 6.2M | $30.6M | 0.1% |
| Suvretta Capital Management, LLC | 4.2M | $20.7M | 0.1% |
| State Street Corporation | 3.8M | $18.6M | 0.0% |
| FCPM III Services B.V. | 2.8M | $13.8M | 0.0% |
| Vanguard Capital Management LLC | 2.8M | $13.5M | 0.0% |
| Shaw D.E. & Co., Inc. | 2.3M | $11.5M | 0.0% |
| Goldman Sachs Group Inc | 2.3M | $11.2M | 0.0% |
Analyst Recommendations
2 Months Ago
8 analysts
Last Month
8 analysts
Current
8 analysts
Strong Buy
Buy
Hold
Sell
Strong Sell
Additional Fundamentals
Enterprise Value
$212.6M
$212.6M
Price/Book
1.86
1.86
Beta
0.116
0.116
Analysts
6
6
Total Debt
$76.3M
$76.3M
Trade Consideration
The Opportunity
Score 33.8 (P27 — top 72.9% of scored tickers). Ethical FAIL. 6 analysts at None.
Price: $4.88 | Target: $3.50 (+-28%)
Score
34
Moat
—
Conviction
Standard
Upside
+-28%
The Fundamentals
Revenue Growth0.0%
Profit Margin0.0%
ROE-90.9%
Forward P/E-2.3
Market Cap$403.4M
Earnings Track Record
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| 2026-05-26 | $-0.73 | Pending | — |
| 2026-02-03 | $-0.82 | $-0.77 | +6.5% |
| 2025-11-06 | $-0.79 | $-0.90 | -13.5% |
| 2025-08-07 | $-0.80 | $-0.95 | -19.2% |
| 2025-05-22 | $-0.69 | $-0.82 | -18.8% |
| 2025-02-12 | $-0.72 | $-0.79 | -9.6% |
Position Sizing Scenarios
Stop: $4.15 (-15%) | Entry: $4.88
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($3.50, 6 analysts) | |||
| 10 | $48.85 | +$-13.80 (-28%) | -1.9R |
| 50 | $244.25 | +$-69.00 (-28%) | -1.9R |
| 100 | $488.50 | +$-138.00 (-28%) | -1.9R |
Risk Factors
- No elevated risk flags in current data
Quantitative Grade
A single score combining all analytical layers below. A is strongest, D is weakest.
B
Quant Score
59.3
Risk Grade
—
Layers
8
Quality: HIGH_VOL
Risk Profile
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
VaR 95%
-7.3%
worst expected daily loss, 19 in 20 days
CVaR 95%
-23.7%
avg loss on the worst 5% of days
Annual Volatility
—
Sortino Ratio
-0.03
above 1.0 is good
Max Drawdown
-88.6%
Worst Day
—
Forward Outlook
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
30d Prob Up
—
90d Prob Up
—
Median Return 30d
—
Liquidity Score
62
Liquidity Grade
LIQUID
Trend & Momentum
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Kalman Trend
—
Trend Strength
—
Momentum Signal
—
HMM Regime
—
RSI Signal
—
Technical Signals
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
MA Crossover
DEATH_CROSS
Bollinger Position
UPPER_HALF
Beta
—
Relative Volume
0.4x
Short Interest
—
Financial Health
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
Altman Z-Score
—
—
below 1.81 = distress zone
Piotroski F-Score
—
Earnings Beat Rate
50.0%
Earnings Consistency
—
Correlations
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
Most Correlated
| Ticker | Correlation |
|---|---|
| LMT | 0.226 |
| BMI | 0.201 |
| PGEN | 0.196 |
| CGON | 0.195 |
| ABEO | 0.193 |
Inverse Correlated
| Ticker | Correlation |
|---|---|
| UPAC.KW | -0.456 |
| CATTL.KW | -0.384 |
| GNCGY | -0.233 |
| CAR | -0.208 |
| DHI | -0.186 |
Seasonality
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
Best Day
Wednesday
Worst Day
Tuesday
Best Month
Oct
Worst Month
Apr
Fri-Mon Effect
0.8363026310645756
Earnings Drift
After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.
Avg Drift After Beat
+3.9%
Beat Drift Positive %
66.7%
Consistency
—
Momentum Rankings
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.
1M Return
+90.1%
3M Return
-45.0%
6M Return
-49.0%
12M Return
-47.5%
Momentum Rank
#1669
Momentum Signal
UP